280 related articles for article (PubMed ID: 22535561)
1. Epidemiology of contrast material-induced nephropathy in the era of hydration.
Balemans CE; Reichert LJ; van Schelven BI; van den Brand JA; Wetzels JF
Radiology; 2012 Jun; 263(3):706-13. PubMed ID: 22535561
[TBL] [Abstract][Full Text] [Related]
2. Incidence of contrast material-induced nephropathy after neuroendovascular procedures.
Prasad V; Gandhi D; Stokum C; Miller T; Jindal G
Radiology; 2014 Dec; 273(3):853-8. PubMed ID: 25102293
[TBL] [Abstract][Full Text] [Related]
3. Is treatment with N-acetylcysteine to prevent contrast-induced nephropathy when using bicarbonate hydration out of date?
Heng AE; Cellarier E; Aublet-Cuvelier B; Decalf V; Motreff P; Marcaggi X; Deteix P; Souweine B
Clin Nephrol; 2008 Dec; 70(6):475-84. PubMed ID: 19049703
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial.
Nijssen EC; Rennenberg RJ; Nelemans PJ; Essers BA; Janssen MM; Vermeeren MA; Ommen VV; Wildberger JE
Lancet; 2017 Apr; 389(10076):1312-1322. PubMed ID: 28233565
[TBL] [Abstract][Full Text] [Related]
5. Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease.
Solomon RJ; Natarajan MK; Doucet S; Sharma SK; Staniloae CS; Katholi RE; Gelormini JL; Labinaz M; Moreyra AE;
Circulation; 2007 Jun; 115(25):3189-96. PubMed ID: 17562951
[TBL] [Abstract][Full Text] [Related]
6. CHA2DS2-VASC score as a preprocedural predictor of contrast-induced nephropathy among patients with chronic total occlusion undergoing percutaneous coronary intervention: a single-center experience.
Wang Y; Zhao HW; Zhang XJ; Chen BJ; Yu GN; Hou AJ; Luan B
BMC Cardiovasc Disord; 2019 Mar; 19(1):74. PubMed ID: 30922230
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Safety Guidelines on the Use of Iodinated Contrast Material: Conundrum Continued.
Nijssen EC; Nelemans PJ; Rennenberg RJ; van Ommen V; Wildberger JE
Invest Radiol; 2018 Oct; 53(10):616-622. PubMed ID: 29762257
[TBL] [Abstract][Full Text] [Related]
8. Can neutrophil gelatinase-associated lipocalin help depict early contrast material-induced nephropathy?
Lacquaniti A; Buemi F; Lupica R; Giardina C; Murè G; Arena A; Visalli C; Baldari S; Aloisi C; Buemi M
Radiology; 2013 Apr; 267(1):86-93. PubMed ID: 23297321
[TBL] [Abstract][Full Text] [Related]
9. Risk of contrast-induced nephropathy for patients receiving intravenous vs. intra-arterial iodixanol administration.
Tong GE; Kumar S; Chong KC; Shah N; Wong MJ; Zimmet JM; Wang ZJ; Yee J; Fu Y; Yeh BM
Abdom Radiol (NY); 2016 Jan; 41(1):91-9. PubMed ID: 26830615
[TBL] [Abstract][Full Text] [Related]
10. Nephrotoxicity of iso-osmolar versus low-osmolar contrast media is equal in low risk patients.
Feldkamp T; Baumgart D; Elsner M; Herget-Rosenthal S; Pietruck F; Erbel R; Philipp T; Kribben A
Clin Nephrol; 2006 Nov; 66(5):322-30. PubMed ID: 17140161
[TBL] [Abstract][Full Text] [Related]
11. [Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial].
Nijssen EC; Rennenberg RJ; Nelemans PJ; Essers BA; Janssen MM; Vermeeren MA; van Ommen V; Wildberger JE
Ned Tijdschr Geneeskd; 2018; 161():D1734. PubMed ID: 29328007
[TBL] [Abstract][Full Text] [Related]
12. Contrast-induced nephropathy in patients undergoing computed tomography (CONNECT) - a clinical problem in daily practice? A multicenter observational study.
Lencioni R; Fattori R; Morana G; Stacul F
Acta Radiol; 2010 Sep; 51(7):741-50. PubMed ID: 20707658
[TBL] [Abstract][Full Text] [Related]
13. Incidence of Contrast-Induced Nephropathy After Renal Graft Catheter Arteriography Using Iodine-Based Contrast Medium.
Fananapazir G; Troppmann C; Corwin MT; Bent CK; Vu CT; Lamba R
AJR Am J Roentgenol; 2016 Apr; 206(4):783-6. PubMed ID: 26866337
[TBL] [Abstract][Full Text] [Related]
14. Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography: a double-blind comparison of iodixanol and iopamidol.
Barrett BJ; Katzberg RW; Thomsen HS; Chen N; Sahani D; Soulez G; Heiken JP; Lepanto L; Ni ZH; Ni ZH; Nelson R
Invest Radiol; 2006 Nov; 41(11):815-21. PubMed ID: 17035872
[TBL] [Abstract][Full Text] [Related]
15. [Effectiveness of nephroprotection by the selection of contrast media used during vascular interventions in patients with chronic renal failure?].
Schönefeld E; Höwler S; Osada N; Torsello G
Zentralbl Chir; 2011 Oct; 136(5):426-30. PubMed ID: 22009540
[TBL] [Abstract][Full Text] [Related]
16. Contrast media and nephropathy: findings from systematic analysis and Food and Drug Administration reports of adverse effects.
Solomon R; Dumouchel W
Invest Radiol; 2006 Aug; 41(8):651-60. PubMed ID: 16829749
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of theophylline in preventing contrast-induced nephropathy after coronary angiographic procedures.
Bilasy ME; Oraby MA; Ismail HM; Maklady FA
J Interv Cardiol; 2012 Aug; 25(4):404-10. PubMed ID: 22612071
[TBL] [Abstract][Full Text] [Related]
18. The lack of benefit of a combination of an angiotensin receptor blocker and calcium channel blocker on contrast-induced nephropathy in patients with chronic kidney disease.
Oguzhan N; Cilan H; Sipahioglu M; Unal A; Kocyigit I; Kavuncuoglu F; Arikan T; Akpek M; Elcik D; Sahin O; Gulme E; Pala C; Tokgoz B; Utas C; Oguzhan A; Oymak O
Ren Fail; 2013; 35(4):434-9. PubMed ID: 23413781
[TBL] [Abstract][Full Text] [Related]
19. High incidence of nephropathy in neurosurgical patients after intra-arterial administration of low-osmolar and iso-osmolar contrast media.
Serafin Z; Karolkiewicz M; Gruszka M; Strózecki P; Lasek W; Odrowaz-Sypniewska G; Manitius J; Beuth W
Acta Radiol; 2011 May; 52(4):422-9. PubMed ID: 21498279
[TBL] [Abstract][Full Text] [Related]
20. Patients at risk for contrast-induced nephropathy and mid-term effects after contrast administration: a prospective cohort study.
Moos SI; Nagan G; de Weijert RS; van Vemde DN; Stoker J; Bipat S
Neth J Med; 2014 Sep; 72(7):363-71. PubMed ID: 25178770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
